Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

Viral Infections, Non-HIV

Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

Pediatrics.

Hofstetter AM, Lacombe K, Klein EJ, Jones C, Strelitz B, Jacobson E, Ranade D, Ward ML, Mijatovic-Rustempasic S, Evans D, Wikswo M, Bowen MD, Parashar UD, Payne DC, Englund JA

doi: 10.1542/peds.2017-1110.

Bacterial Infections

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

Vaccine

Abu-Elyazeed R, Klein NP, Moerman L, Povey M, Pruitt A, Senders S, Silas P, Bi D, Rota-090 Study Group.

doi: 10.1016/j.vaccine.2020.08.070

Viral Infections, Non-HIV

Polio endgame: Lessons for the global rotavirus vaccination program

Vaccine.

Jiang B, Patel M, Glass RI

doi: 10.1016/j.vaccine.2019.04.023.

Viral Infections, Non-HIV

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Vaccine.

Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D

doi: 10.1016/j.vaccine.2019.12.017.

Viral Infections, Non-HIV

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial

Vaccine.

Leung TF, Liu AP, Lim FS, Thollot F, Oh HML, Lee BW, Rombo L, Tan NC, Rouzier R, De Simoni S, Suryakiran P, Hezareh M, Thomas F, Folschweiller N, Struyf F

Viral Infections, Non-HIV

Skin thickness in neonates: Implications for intradermal vaccination

Vaccine.

Saitoh A, Nirei J, Tanaka T, Haniu H, Sakai T, Okubo S, Hirano H

doi: 10.1016/j.vaccine.2020.06.061.

Viral Infections, Non-HIV

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx

Vaccine.

Hales C, Jochems SP, Robinson R, Solórzano C, Carniel B, Pojar S, Reiné J, German EL, Nikolaou E, Mitsi E, Hyder-Wright AD, Hill H, Adler H, Connor V, Zaidi S, Lowe C, Fan X, Wang D, Gordon SB, Rylance J, Ferreira DM

doi: 10.1016/j.vaccine.2020.01.070.

Viral Infections, Non-HIV

Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus

Vaccine.

Mok CC, Ho LY, To CH

doi: 10.1016/j.vaccine.2018.04.056.

Viral Infections, Non-HIV

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Clin Infect Dis.

Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, Curns AT, Sulemana I, Esona MD, Bowen MD, Parashar UD, and the New Vaccine Surveillance Network (NVSN).

doi: 10.1093/cid/ciaa150.

Related content

Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

Polio endgame: Lessons for the global rotavirus vaccination program

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial

Skin thickness in neonates: Implications for intradermal vaccination

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx

Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14 years: Results to month 36 from a randomized trial